Tandem Diabetes Care, Inc. Research and Development in Process
Tandem Diabetes Care, Inc. (TNDM) reported Research and Development in Process of $78.75 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2023-05-03
- Tandem Diabetes Care, Inc. research and development in process for the quarter ending 2023-03-31 was $78.75M.
- Tandem Diabetes Care, Inc. research and development in process for the quarter ending 2022-12-31 was $23.00K.
- Tandem Diabetes Care, Inc. research and development in process for the quarter ending 2022-09-30 was $31.02M.
- Tandem Diabetes Care, Inc. research and development in process for the quarter ending 2022-03-31 was $0.00.
- Tandem Diabetes Care, Inc. research and development in process for fiscal 2022 was $31.04M.
- Tandem Diabetes Care, Inc. research and development in process for fiscal 2021 was $0.00.
- Tandem Diabetes Care, Inc. research and development in process for fiscal 2020 was $0.00.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month |
|---|---|---|---|---|
| 2023-03-31 | $78.75M 10-Q · filed 2023-05-03 | $78.77M derived: sum of 2 quarters · filed 2023-05-03 | $109.79M derived: sum of 3 quarters · filed 2023-05-03 | |
| 2022-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $31.04M derived: sum of 2 quarters · filed 2023-02-22 | $31.04M 10-K · filed 2023-02-22 | |
| 2022-09-30 | $31.02M 10-Q · filed 2022-11-02 | $31.02M 10-Q · filed 2022-11-02 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2023-05-03 | $0.00 derived: sum of 3 quarters · filed 2023-05-03 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $0.00 derived: sum of 2 quarters · filed 2023-02-22 | $0.00 10-K · filed 2023-02-22 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |